14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.90 $2.79 Thursday, 25th Apr 2024 FGEN stock ended at $1.02. This is 3.63% more than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 13.75% from a day low at $0.90 to a day high of $1.03.
90 days $0.88 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Jan 13, 2021 $39.42 $39.95 $38.80 $39.35 468 407
Jan 12, 2021 $38.37 $39.63 $37.89 $39.47 660 855
Jan 11, 2021 $38.39 $39.30 $38.01 $38.41 421 306
Jan 08, 2021 $39.48 $39.87 $38.14 $38.40 565 799
Jan 07, 2021 $38.75 $39.70 $38.40 $39.48 520 713
Jan 06, 2021 $38.34 $38.70 $37.60 $38.31 670 797
Jan 05, 2021 $37.70 $38.48 $37.43 $37.98 385 671
Jan 04, 2021 $37.42 $38.48 $36.94 $37.58 625 003
Dec 31, 2020 $37.80 $37.88 $36.86 $37.09 981 169
Dec 30, 2020 $37.92 $39.00 $37.77 $37.97 612 219
Dec 29, 2020 $39.20 $39.21 $37.88 $37.97 583 959
Dec 28, 2020 $40.96 $41.40 $38.69 $38.91 749 006
Dec 24, 2020 $40.72 $41.43 $40.19 $40.41 325 935
Dec 23, 2020 $40.82 $40.82 $39.82 $40.48 635 940
Dec 22, 2020 $40.28 $40.77 $39.53 $40.45 842 605
Dec 21, 2020 $39.52 $41.85 $37.60 $40.01 3 411 477
Dec 18, 2020 $44.16 $45.64 $43.27 $43.97 1 910 440
Dec 17, 2020 $43.12 $44.47 $41.87 $44.24 738 307
Dec 16, 2020 $41.61 $42.18 $40.80 $41.96 881 196
Dec 15, 2020 $43.60 $43.60 $41.29 $41.66 1 097 534
Dec 14, 2020 $41.97 $44.44 $41.62 $43.91 987 308
Dec 11, 2020 $40.08 $41.43 $39.85 $41.01 854 519
Dec 10, 2020 $40.90 $41.48 $40.02 $40.27 540 030
Dec 09, 2020 $42.47 $42.55 $40.39 $41.07 693 113
Dec 08, 2020 $41.83 $42.35 $41.18 $42.23 528 131
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT